BEIJING, June 30, 2025 (GLOBE NEWSWIRE) -- TIAN RUIXIANG Holdings Ltd (Nasdaq: TIRX) (the “Company” or “TRX”), a China-based insurance broker, today announced it has completed the acquisition of 100% of issued and outstanding shares of Ucare Inc. (“Ucare”), the sole operator of China’s only cloud-based AI-driven hospital and health insurance risk management platform. The all-stock transaction, valued at US$150 million, marks a major milestone in TRX’s strategy to expand into in-hospital distribution channel ...

Core Insights - Zacks Premium provides various tools for investors to enhance their stock market strategies, including daily updates on Zacks Rank and Industry Rank, access to the Zacks 1 Rank List, Equity Research reports, and Premium stock screens [1] Zacks Style Scores - Zacks Style Scores are indicators that assist investors in selecting stocks likely to outperform the market within 30 days, rated from A to F based on value, growth, and momentum characteristics [2] - The Style Scores consist of four categories: Value Score, Growth Score, Momentum Score, and VGM Score, each focusing on different investment strategies [3][4][5][6] Value Score - The Value Score identifies attractive and discounted stocks using ratios such as P/E, PEG, Price/Sales, and Price/Cash Flow, appealing to value investors [3] Growth Score - The Growth Score emphasizes a company's financial strength and future outlook, analyzing projected and historical earnings, sales, and cash flow to find stocks with sustainable growth [4] Momentum Score - The Momentum Score helps investors capitalize on price trends, utilizing factors like one-week price changes and monthly earnings estimate changes to identify optimal buying times [5] VGM Score - The VGM Score combines the three Style Scores to highlight companies with the best value, growth forecasts, and momentum, serving as a strong indicator alongside the Zacks Rank [6] Zacks Rank - The Zacks Rank is a proprietary model based on earnings estimate revisions, aiding investors in building successful portfolios, with 1 (Strong Buy) stocks historically yielding an average annual return of +25.41% since 1988 [7][8] Stock to Watch: Henry Schein Inc. - Henry Schein Inc. is a leading global distributor of healthcare products and services, operating in 33 countries and serving various healthcare practitioners [11] - Currently rated 3 (Hold) on the Zacks Rank, Henry Schein has a VGM Score of A and a Value Style Score of A, with a forward P/E ratio of 15.06, indicating attractive valuation metrics [11][12] - The company has seen upward revisions in earnings estimates, with the Zacks Consensus Estimate increasing by $0.02 to $4.86 per share for fiscal 2025, and an average earnings surprise of 2.4% [12]

Core Insights - Zacks Premium offers various tools for investors to enhance their stock market strategies and confidence [1] - The Zacks Style Scores provide a framework for evaluating stocks based on value, growth, and momentum characteristics [2][3][4][5][6] Zacks Style Scores - The Style Scores categorize stocks into four types: Value Score, Growth Score, Momentum Score, and VGM Score, each focusing on different investment strategies [3][4][5][6] - Value Score emphasizes finding undervalued stocks using metrics like P/E and Price/Sales ratios [3] - Growth Score assesses stocks based on projected earnings and sales growth [4] - Momentum Score identifies stocks with favorable price trends and earnings outlooks [5] - VGM Score combines all three styles to highlight stocks with the best overall potential [6] Zacks Rank - The Zacks Rank is a proprietary model that uses earnings estimate revisions to help investors build successful portfolios [7] - Stocks rated 1 (Strong Buy) have historically outperformed the market, with an average annual return of +25.41% since 1988 [8] - There are over 800 stocks rated 1 or 2, making it essential for investors to utilize Style Scores to narrow down choices [9] Stock Example: Prestige Consumer Healthcare (PBH) - Prestige Consumer Healthcare Inc. develops and sells OTC healthcare products across various markets [11] - PBH holds a 3 (Hold) rating on the Zacks Rank and has a VGM Score of B, indicating solid potential [12] - The company has a forward P/E ratio of 17, making it attractive for value investors [12] - Recent upward revisions in earnings estimates suggest positive momentum, with the Zacks Consensus Estimate for fiscal 2026 at $4.76 per share [12] - With strong Value and VGM Style Scores, PBH is recommended for investors' consideration [13]

[Music] My name is Cena Medina. I'm a lead data scientist and AI engineer at City of Hope National Medical Center. City of Hope is a national medical center specialized in cancer care and diabetes.We've developed Hope LLM, an agentic application built with Langin and Langraph. Our goal was to transform how physicians interact with patient data by automating patient journey summarization. Physicians frequently face time constraints when reviewing extensive documentation, including PDFs, imaging reports, and ...

Group 1 - CVS Health will hold a conference call on July 31, 2025, at 8:00 a.m. ET to discuss its second quarter 2025 financial results [1] - An audio webcast of the conference call will be available on the CVS Health Investor Relations website and archived for one year [1] Group 2 - As of March 31, 2025, CVS Health operates over 9,000 retail pharmacy locations and more than 1,000 walk-in and primary care medical clinics [2] - The company is a leading pharmacy benefits manager with approximately 88 million plan members and serves over 800,000 patients annually through its senior pharmacy care business [2] - CVS Health provides health insurance products and services to an estimated 37 million people, including Medicare Advantage offerings and a standalone Medicare Part D prescription drug plan [2] - The company's integrated model focuses on personalized, technology-driven services to enhance access to quality care, improve health outcomes, and reduce overall costs [2]

Company Overview - Clover Health Investments, Corp. is a physician enablement technology company focused on providing access to quality healthcare for Medicare recipients, particularly seniors who have historically faced challenges in accessing affordable healthcare [5] - The company utilizes its software platform, Clover Assistant, to aggregate patient data and support clinical decision-making, aiming to improve health outcomes through early identification and management of chronic diseases [5] Recent Developments - Clover Health announced its inclusion in the Russell 3000® Index, effective June 30, 2025, as part of the annual reconstitution of the Russell indexes [1][2] - This inclusion is expected to enhance the company's visibility within the investment community and is seen as a significant achievement in broadening awareness and engagement [3] Market Context - The Russell 3000® Index includes the 4,000 largest US stocks ranked by total market capitalization as of April 30, 2025, and membership lasts for one year [2] - Membership in the Russell 3000® Index also grants automatic inclusion in either the large-cap Russell 1000® Index or the small-cap Russell 2000® Index, along with relevant growth and value style indexes [2] Industry Impact - The Russell indexes are widely utilized by investment managers and institutional investors, with approximately $10.6 trillion in assets benchmarked against them as of June 2024 [3] - FTSE Russell, the provider of these indexes, is recognized for its objective market capitalization and style attributes in determining membership [2][3]

Core Viewpoint - NextPlat Corp is undergoing a strategic review and operational restructuring following the unexpected passing of its former CEO, with a focus on enhancing its healthcare division and expanding e-commerce capabilities to unlock growth opportunities [2][3][9]. Company Overview - NextPlat Corp is a global consumer products and services company that provides healthcare and technology solutions through e-commerce and retail channels worldwide [10]. Current Operations - The healthcare division is identified as the largest part of the business, presenting significant untapped opportunities [3]. - The retail pharmacy sector is facing challenges due to rising drug costs and reimbursement rates not keeping pace, necessitating a focus on operational efficiency and investment in alternative healthcare areas [3][4]. Strategic Initiatives - Streamlining healthcare operations and expanding contracted 340B and long-term care services are key areas for profitable growth [4]. - The company plans to enhance operational efficiencies, reduce costs, and ensure the right talent is in place to drive growth [5][12]. - There is a commitment to invest prudently in both organic and non-organic growth opportunities while enhancing cash flow and long-term profitability [5][12]. E-Commerce Expansion - E-commerce, although currently a smaller part of the business, presents vast global opportunities through partnerships with major marketplaces like Amazon, Walmart, and Alibaba [7]. - The company aims to grow its e-commerce business through various initiatives, including launching new international marketplaces and forming distribution partnerships [11]. Future Outlook - The company is focused on maximizing efficiencies and generating positive operating results, with plans to fill gaps in the team and empower leaders to execute growth plans [12]. - There is an ongoing effort to improve shareholder transparency and engagement, including outreach to the broader investor community [12].

Company Overview - Nutex Health Inc. is a physician-led, integrated healthcare delivery system with 24 micro hospitals and hospital outpatient departments (HOPDs) across 11 states [1][4] - The company operates two divisions: a Hospital Division and a Population Health Management Division [4][5] Recent Developments - Nutex Health has filed a supplement to its proxy statement on June 27, 2025, encouraging shareholders to review the new information [1] - The company's Annual Meeting of common stockholders is scheduled for July 14, 2025, at 10:00 am Central Time [2] Shareholder Information - Stockholders can access the definitive proxy statement dated June 2, 2025, and the Form 10-K online or request a free paper or email copy [2][3] - Instructions for requesting materials include visiting a specific website, calling a designated number, or sending an email with a control number [3]

Singapore, June 26, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”), today announced that Cathay Securities, Inc., as the representative of the several underwriters of the Company’s initial public offering, has granted its consent on June 23, 2025 to the lock-up provision in the underwriting agreement dated February 24, 2025, permitting (i) a public offering or private placement of new securities of the Company, and (ii) the filing with the U.S. Securities and Exchange Commis ...

Core Insights - Marsh & McLennan Companies, Inc. (MMC) is set to acquire Validate Health, a healthcare analytics firm, with the deal expected to finalize by summer 2025 [1][10] - The acquisition aims to enhance Oliver Wyman's actuarial capabilities and provide healthcare providers with advanced data-driven tools [2][10] - This move reflects a trend among consulting firms to integrate technology-enabled services alongside traditional advisory roles [3][10] Group 1: Acquisition Details - The acquisition of Validate Health will strengthen Oliver Wyman's analytics capabilities, improving patient outcomes and supporting Accountable Care Organizations (ACOs) in value-based care [2][10] - The integration of consulting expertise with actionable analytics is anticipated to set a new standard in the healthcare consulting sector [3][4] Group 2: Financial Performance - In Q1 2025, Oliver Wyman reported a revenue growth of 4% year-over-year, reaching $818 million [4] - MMC has been actively pursuing strategic acquisitions and diversifying into emerging markets, with notable recent deals including McGriff Insurance Services for $7.75 billion [5][10] Group 3: Stock Performance - Year-to-date, MMC shares have increased by 1.8%, while the industry has seen a growth of 4.1% [6] - MMC currently holds a Zacks Rank of 3 (Hold), with better-ranked stocks in the finance sector including Pagaya Technologies, Heritage Insurance, and Acadian Asset Management [7]